Figure 4.
Average daily change in FEV1 from baseline by treatment group. Gray circles, patients treated with ceftaz/tobra. Open circles, patients treated with mero/tobra. Sample sizes for measures are in parentheses.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.